Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis

Endocrine Regulations- Germany

doi 10.1515/enr-2016-0009

Full Text

Abstract

Available in

Date

Authors

Publisher

Walter de Gruyter GmbH

Related search

Hashimoto’s Thyroiditis

2014English

Hashimoto’s Thyroiditis and Encephalopathy

World Journal of Neuroscience
2017English

Th17/Treg Cells Imbalance and GITRL Profile in Patients With Hashimoto’s Thyroiditis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Hashimoto’s Thyroiditis and Autoimmune Gastritis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Plasma YKL-40 as a Biomarker for Bevacizumab Efficacy in Patients With Newly Diagnosed Glioblastoma in the Phase 3 Randomized AVAglio Trial

Oncotarget
Oncology
2017English

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2014English

Effect of L-Thyroxine Treatment on Peripheral Blood Dendritic Cell Subpopulations in Patients With Hashimoto’s Thyroiditis

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2014English

Cognitive Function in Hashimoto’s Thyroiditis Under Levothyroxine Treatment

Hormones
MedicineEndocrinologyMetabolismDiabetes
2014English

Research Progress on IgG4-Related Hashimoto’s Thyroiditis

Infection International
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy